Vakharia V N, Guilfoyle M R, Laing R J
Department of Neurosurgery, Addenbrooke's Hospital, Cambridge, UK.
Br J Neurosurg. 2012 Feb;26(1):7-11. doi: 10.3109/02688697.2011.578771. Epub 2011 May 18.
To assess the outcome in patients with syrinx and non-syrinx associated Chiari malformations undergoing Foramen Magnum Decompression (FMD).
Sixty-one patients undergoing FMD for Chiari malformations were prospectively studied with disease specific, generic (SF 36) and subjective (patient reported) outcomes. Of these, 34 patients had objective outcome data including SF36, visual analogue pain scores, Neck and Myelopathy disability indices and the Hospital anxiety and depression score. SF 36 scores were compared to normative data. Data were collected pre-operatively, at 3 months and during long-term follow up (12-60 months).
Patient reported improvements in headache and neck pain post-operatively was reported in both syrinx and non-syrinx associated patients. Visual Analogue scores showed improvements in arm pain, paresthesia and hand tingling at 3 months in the syrinx group only. Non-syrinx patients showed significant improvements post-operatively in the Neck disability index and the SF-36 domains for physical function, role physical and bodily pain. Comparison with SF-36 normative data indicates that patients still have significantly impaired quality of life 12 months post-operatively.
FMD is able to relieve symptoms and improve quality of life in patients with both syrinx and non-syrinx associated Chiari malformations. In syrinx patients we observed symptomatic improvement in limb symptoms as well as radiological resolution of the syrinx. The use of SF-36 allows the health gain associated with FMD to be quantified. SF 36 is not adequate as a stand alone measure of outcome in this complex disorder and we advocate the concurrent use of disease specific measures and post-operative imaging of the syrinx.
评估患有脊髓空洞症和非脊髓空洞症相关的Chiari畸形患者接受枕骨大孔减压术(FMD)后的结果。
对61例因Chiari畸形接受FMD的患者进行前瞻性研究,采用疾病特异性、通用(SF 36)和主观(患者报告)结果指标。其中,34例患者有客观结果数据,包括SF36、视觉模拟疼痛评分、颈部和脊髓病残疾指数以及医院焦虑和抑郁评分。将SF 36评分与标准数据进行比较。在术前、术后3个月以及长期随访(12 - 60个月)期间收集数据。
脊髓空洞症和非脊髓空洞症相关患者术后均报告头痛和颈部疼痛有所改善。视觉模拟评分仅显示脊髓空洞症组在术后3个月时手臂疼痛、感觉异常和手部刺痛有所改善。非脊髓空洞症患者术后颈部残疾指数以及SF - 36身体功能、角色身体和身体疼痛领域有显著改善。与SF - 36标准数据比较表明,患者术后12个月生活质量仍有明显受损。
FMD能够缓解脊髓空洞症和非脊髓空洞症相关Chiari畸形患者的症状并改善生活质量。在脊髓空洞症患者中,我们观察到肢体症状有症状改善以及脊髓空洞症的影像学消退。使用SF - 36可量化与FMD相关的健康获益。在这种复杂疾病中,SF 36不足以作为单独的结果衡量指标,我们主张同时使用疾病特异性指标和脊髓空洞症的术后影像学检查。